Zoetis (ZTS) Deferred Taxes (2012 - 2026)
Zoetis (ZTS) reported Deferred Taxes of $34.0 million for Q1 2026, up 142.86% year-over-year from $14.0 million in Q1 2025, and up 170.83% quarter-over-quarter from -$48.0 million in Q4 2025.
Zoetis (ZTS) Deferred Taxes (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has 15 years of Deferred Taxes data on file, last reported at $34.0 million in Q1 2026.
- Deferred Taxes for Q1 2026 came in at $34.0 million, up 142.86% year-over-year; the trailing twelve-month figure through Mar 2026 was -$32.0 million (up 88.61% YoY), and the FY2025 annual result was -$52.0 million, up 84.62% from the prior year.
- Deferred Taxes climbed to $34.0 million in Q1 2026 per ZTS's latest filing, from -$48.0 million in the prior quarter.
- Over five years, Deferred Taxes peaked at $34.0 million in Q1 2026 and troughed at -$176.0 million in Q4 2022.
- A 5-year average of -$41.4 million and a median of -$34.0 million in 2022 frame the typical range for Deferred Taxes.
- The sharpest annual moves came in 2024 and 2026: Deferred Taxes tumbled 637.5% in 2024, then soared 142.86% in 2026.
- A 5-year view of Deferred Taxes shows it stood at -$176.0 million in 2022, then surged by 88.07% to -$21.0 million in 2023, then tumbled by 623.81% to -$152.0 million in 2024, then soared by 68.42% to -$48.0 million in 2025, then soared by 170.83% to $34.0 million in 2026.
- Business Quant data shows ZTS's Deferred Taxes at $34.0 million in Q1 2026, -$48.0 million in Q4 2025, and -$16.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -22.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 34.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 25.90 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 14,341.73 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | -61.10 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -8.79 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 19.33 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -13.98 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34.00 Mn |
| Dec 31, 2025 | -48.00 Mn |
| Sep 30, 2025 | -16.00 Mn |
| Jun 30, 2025 | -2.00 Mn |
| Mar 31, 2025 | 14.00 Mn |
| Dec 31, 2024 | -152.00 Mn |
| Sep 30, 2024 | -42.00 Mn |
| Jun 30, 2024 | -101.00 Mn |
| Mar 31, 2024 | -43.00 Mn |
| Dec 31, 2023 | -21.00 Mn |
| Sep 30, 2023 | -14.00 Mn |
| Jun 30, 2023 | -34.00 Mn |
| Mar 31, 2023 | 8.00 Mn |
| Dec 31, 2022 | -176.00 Mn |
| Sep 30, 2022 | -34.00 Mn |
| Jun 30, 2022 | -31.00 Mn |
| Mar 31, 2022 | -45.00 Mn |
| Dec 31, 2021 | 41.00 Mn |
| Sep 30, 2021 | -97.00 Mn |
| Jun 30, 2021 | -11.00 Mn |